# ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

> **NCT01388166** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1253 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **PROCEDURE:** Education

## Key facts

- **NCT ID:** NCT01388166
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 1253 (ACTUAL)
- **Last updated:** 2014-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388166, "ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01388166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*